Susquehanna International Group, LLP 9 Meters Biopharma, Inc. Put Options Transaction History

Susquehanna International Group, LLP

1 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.21 - $0.32 $16,506 - $25,152	-78,600 Reduced 42.56%	106,100 $23,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.